Can Selective Ligands for Glutamate Binding Proteins be Rationally Designed?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|8|823-847

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.8, 2006-04, pp. : 823-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G-Quadruplex Binding Ligands: from Naturally Occurring to Rationally Designed Molecules

By  

Current Pharmaceutical Design, Vol. 18, Iss. 14, 2012-05 ,pp. : 1948-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Binding-Site Ligands of NMDA Receptors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 36, 2011-12 ,pp. : 5483-5506

Bentham Science Publishers

Access to resources Recommend Favorite

Rational use of "rationally designed drugs"

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Rationally Designed Multitarget Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 20, Iss. 13, 2013-04 ,pp. : 1694-1714

Bentham Science Publishers

Access to resources Recommend Favorite

New perspectives for the development of selective metabotropic glutamate receptor ligands

By Pin J.-P.   De Colle C.   Bessis A.-S.   Acher F.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 277-294

Elsevier

Access to resources Recommend Favorite